Precise Gene Signature for Predicting Outcomes in PDAC

Clinical trial NCT05441189 · COMPLETED

Trial details

NCT number: NCT05441189
Sponsor: The Fourth Affiliated Hospital of Anhui Medical University
Status: COMPLETED
Study type: OBSERVATIONAL

Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC)Precise Prognostic and Predictive Signature

Start date: 2021-04-19
Primary completion: 2022-05-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.